Literature DB >> 12471422

Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).

Solange Artimos de Oliveira1, Luiz Antonio Bastos Camacho, Antonio Carlos de Medeiros Pereira, Tereza Filomena Faillace, Sérgio Setubal, Jussara Pereira do Nascimento.   

Abstract

This study was designed to analyse the clinical and epidemiological data from human parvovirus B19 cases in a six-year study of rash diseases conduct in an urban area in Brazil (Niterói city area, State of Rio de Janeiro). A total of 673 patients with acute rash diseases were seen at two primary health care units and at a general hospital. A clotted blood sample was collected from all subjects at the time of consultation. Forty-nine per cent (330 cases) of the patients were negative for dengue, rubella and measles IgM or for low avidity IgG to HHV-6. Of these 330, 105 (31.8%) were identified as IgM positive to parvovirus B19 by using an antibody capture EIA. During the study period, three distinct peaks of parvovirus infection were detected, suggesting that the disease appears to cycle in approximately 4-5 years. B19 infection was characterized by variable combinations of fever, flu-like symptoms, arthropathy, and gastrointestinal symptoms. Frequency of fever and arthropathy was substantially higher in adults, 75% [chi2 (1 D.F.) = 11.39, p = 0.0007] and 62.5% [chi2 (1 D.F.) = 29.89, p = 0.0000], respectively. "Slapped-cheek" appearance and reticular or lace-like rash were seen in only 30.1% of the children. No adult presented this typical rash. The lack of the typical rash pattern in a large proportion of parvovirus B19 and the similarity of clinical manifestations to other rash diseases, specially to rubella, highlight the difficulty of diagnosing B19 infection on clinical grounds alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471422

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Relationship between temperature change and the requirement for a permanent pacemaker implantation in bradyarrhythmias.

Authors:  I-Fan Liu; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Chi-Woon Kong; Tsu-Juey Wu; Chern-En Chiang; Shih-Ann Chen; Yenn-Jiang Lin
Journal:  Int J Biometeorol       Date:  2011-01-05       Impact factor: 3.787

3.  Comprehensive surveillance data suggest a prominent role of parvovirus B19 infection in Belarus and the presence of a third subtype within subgenotype 1a.

Authors:  Marina A Yermalovich; Alina M Dronina; Galina V Semeiko; Elena O Samoilovich; Vladislav V Khrustalev; Aurelie Sausy; Judith M Hübschen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

4.  Gastrointestinal lesions in parvovirus B19 infection.

Authors:  Davide Tassinari; Giorgio Gallinella; Nunzio C Salfi; Daniela Elleri; Sara Forti; Francesca Bonvicini; Filippo Bernardi
Journal:  BMJ Case Rep       Date:  2009-03-17

5.  Use of oral fluid samples for the investigation of outbreaks of human parvovirus B19 infection.

Authors:  Daiana Lima Almada; Arthur Daniel Rocha Alves; Luciane Almeida Amado Leon; Débora Familiar Rodrigues Macedo; Solange Artimos de Oliveira; Marilda Mendonça Siqueira; David Brown; Rita de Cássia Nasser Cubel Garcia
Journal:  Braz J Microbiol       Date:  2022-09-23       Impact factor: 2.214

6.  Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran.

Authors:  Seyed Ali Mohammad Arabzadeh; Farideh Alizadeh; Ahmad Tavakoli; Hamidreza Mollaei; Farah Bokharaei-Salim; Gharib Karimi; Mohammad Farahmand; Helya Sadat Mortazavi; Seyed Hamidreza Monavari
Journal:  Blood Res       Date:  2017-03-27

7.  Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Authors:  Marion Dollat; Benjamin Chaigne; Grégoire Cormier; Nathalie Costedoat-Chalumeau; François Lifermann; Alban Deroux; Emilie Berthoux; Emmanuelle Dernis; Thomas Sené; Gilles Blaison; Olivier Lambotte; Benjamin Terrier; Jérémie Sellam; Luc De Saint-Martin; Laurent Chiche; Nicolas Dupin; Luc Mouthon
Journal:  BMC Infect Dis       Date:  2018-07-04       Impact factor: 3.090

8.  Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil.

Authors:  Arthur Daniel Rocha Alves; Jéssica Vasques Raposo; Rafaela Moraes Pereira de Sousa; Claudete Aparecida Araújo Cardoso; Pâmela Karla Simões de Freitas Costa; Julienne Martins Araújo; Sabrina Teresinha Alvim Barreiro; Clarisse da Silveira Bressan; Guilherme Amaral Calvet; Rogério Valls de Souza; Patrícia Brasil; Rita de Cássia Nasser Cubel Garcia; Marcelo Alves Pinto; Vanessa Salete de Paula; Luciane Almeida Amado
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

9.  Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.

Authors:  Hartwig W Lehmann; Annelie Plentz; Philipp von Landenberg; Rolf-M Küster; Susanne Modrow
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 3.650

10.  Acute arthropathy in patients with rash diseases: a comparative study.

Authors:  Solange Artimos de Oliveira; Luiz Antonio Bastos Camacho; Letícia Fernandes Bruno; Rodrigo Coimbra de Gusmão; Antonio Carlos de Medeiros Pereira; Luis Guillermo Coca Velarde; Marilda Mendonça Siqueira
Journal:  Clin Rheumatol       Date:  2009-05-05       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.